Study Evaluating Safety and Efficacy of CAR-T Cells Targeting CD123 in Patients With Acute Myelocytic Leukemia

NCT03796390 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
15
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Hebei Senlang Biotechnology Inc., Ltd.

Collaborators